POPULATION PHARMACOKINETICS OF RELATLIMAB, A FULLY HUMAN LAG-3-SPECIFIC ANTIBODY, IN PATIENTS WITH ADVANCED SOLID TUMORS AND RELAPSED OR REFRACTORY B-MALIGNANCIES.

作者： J Zhang , SP Bathena , S Chapel , E Briggs , M Maurer